1. Gilead says remdesivir cut risk of COVID patient death in clinical trial — BioNTech-Pfizer COVID vaccine expected to be ready for approval by year end — LEO Pharma eyeing 2021 launch for Dupixent rival — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Atherotech

Anonymous board for Atherotech

Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    105
    Views:
    35,664
  2. anonymous
    Replies:
    4
    Views:
    1,366
  3. anonymous
    Replies:
    7
    Views:
    4,217
  4. anonymous
    Replies:
    1
    Views:
    1,996
  5. anonymous
    Replies:
    9
    Views:
    707
  6. anonymous
    Replies:
    0
    Views:
    2,081
  7. anonymous
    Replies:
    3
    Views:
    3,296
  8. anonymous
    Replies:
    20
    Views:
    6,351
  9. anonymous
    Replies:
    2
    Views:
    2,048
  10. anonymous
    Replies:
    8
    Views:
    3,758
  11. anonymous
    Replies:
    10
    Views:
    3,148
  12. Happy from Ningbo China
    Replies:
    2
    Views:
    2,087
  13. anonymous
    Replies:
    2
    Views:
    2,065
  14. anonymous
    Replies:
    3
    Views:
    2,023
  15. anonymous
    Replies:
    4
    Views:
    1,916
  16. anonymous
    Replies:
    5
    Views:
    1,840
  17. anonymous
    Replies:
    6
    Views:
    2,045
  18. anonymous
    Replies:
    37
    Views:
    8,215
  19. anonymous
    Replies:
    37
    Views:
    8,654
  20. anonymous
    Replies:
    1
    Views:
    4,071

Thread Display Options

Loading...